ARYA Sciences Acquisition Corp. III (ARYA) to Combine with Nautilus Biotechnology in $905M Deal

nautilus-biotechnology

ARYA Sciences Acquisition Corp. III (ARYA) to Combine with Nautilus Biotechnology in $905M Deal

ARYA Sciences Acquisition Corp. III (Nasdaq:ARYA) has entered into a definitive agreement to combine with Nautilus Biotechnology, Inc. for an enterprise value of $905 million. Nautilus is working to create a machine-learning technology platform for testing and mapping proteins and serve as an accelerant in biopharmaceutical research. The combined entity is expected to trade on
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.